P3 Health Partners Inc.
Organization details
- Legal name
- P3 Health Partners Inc.
- Former names
- Foresight Acquisition Corp.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 8000 — Services-Health Services
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Chicago
- Headquarters state / province
- Illinois
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- PIII
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001832511
- EIN
- 85-2992794
Board of directors
-
Amir Bacchus · Director · Chief Medical OfficerSince 2023
-
Gregory D. Wasson · DirectorSince 2024
-
Gregory N. Kazarian · DirectorSince 2024
-
Jeffrey G. Park · DirectorSince 2024
-
Lawrence B. Leisure · DirectorSince 2024
-
Mark Thierer · DirectorSince 2024
-
Mary A. Tolan · DirectorSince 2024
-
Sherif Abdou · Director · Chief Executive OfficerSince 2023
-
Thomas Edmunds Price · DirectorSince 2024
Chief executives
Director election results
Annual meeting of June 9, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
97.1%
-
99.2%
-
99.6%
Board connections
3 of this board's directors also sit on 3 other boards. 2 are in the same sector.
-
DarioHealth Corp. Same sectorvia Lawrence B. Leisure
- via Gregory D. Wasson
-
Progyny Inc. Same sectorvia Jeffrey G. Park
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $823,927
- 3 sales by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 13, 2026 | Hudson Vegas Investment SPV, LLC 10% owner | Derivative conversion | +100,000 | — | — |
| Aug 13, 2026 | Hudson Vegas Investment SPV, LLC 10% owner | Other | −100,000 | — | — |
| Aug 10, 2026 | Hudson Vegas Investment Manager, LLC 10% owner | Open-market sale | −1,041 | $13.38 | $13,929 |
| Aug 10, 2026 | Hudson Vegas Investment Manager, LLC 10% owner | Open-market sale | −19,074 | $16.05 | $306,138 |
| Aug 10, 2026 | Hudson Vegas Investment Manager, LLC 10% owner | Open-market sale | −29,885 | $16.86 | $503,861 |
| Jun 10, 2026 | Hudson Vegas Investment SPV, LLC 10% owner | Derivative conversion | +50,000 | — | — |
| Jun 10, 2026 | Hudson Vegas Investment SPV, LLC 10% owner | Other | −50,000 | — | — |
| Aug 6, 2025 | Gregory N. Kazarian Director | Grant or award | +2,000 | — | — |
| Aug 6, 2025 | Mary A. Tolan Director | Grant or award | +2,000 | — | — |
| Aug 6, 2025 | Mark Thierer Director | Grant or award | +4,000 | — | — |
| Aug 6, 2025 | Gregory D. Wasson Director | Grant or award | +2,000 | — | — |
| Aug 6, 2025 | Jeffrey G. Park Director | Grant or award | +2,000 | — | — |
| Aug 6, 2025 | Lawrence B. Leisure Director | Grant or award | +2,000 | — | — |
| Aug 6, 2025 | Thomas Edmunds Price Director | Grant or award | +2,000 | — | — |
| Sep 13, 2024 | CPF III-A PT SPV, LLC 10% owner | Open-market purchase | +80,000 | $0.50 | $40,000 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about P3 Health Partners Inc.
Who is the CEO of P3 Health Partners Inc.?
Sherif Abdou is P3 Health Partners Inc.'s Chief Executive Officer.
How many directors are on P3 Health Partners Inc.'s board?
P3 Health Partners Inc.'s board has 9 directors: Amir Bacchus, Gregory D. Wasson, Gregory N. Kazarian, Jeffrey G. Park, Lawrence B. Leisure, Mark Thierer, Mary A. Tolan, Sherif Abdou and Thomas Edmunds Price.
Are P3 Health Partners Inc. insiders buying or selling shares?
Over the last 12 months, P3 Health Partners Inc. insiders made no open-market purchases and sold $823,927 of shares in 3 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="p3-health-partners-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.